A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study ID
- NCT07655934
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Survey completion — OTHERSurveys will evaluate dietary quality, physical activity, tobacco use, demographic and socio-economic/occupation factors and perspectives about participation in biomedical/biospecimen research.
- Urine specimen banking — OTHERThe study team will collect the first urine of the day from these volunteers on the same day that they complete the lifestyle questionnaires. The urine will be used for metabolomics testing via Nuclear Magnetic Resonance (NMR) spectroscopy and will be correlated with the survey data.
- Qualitative interviews — OTHERAfter the survey and urine specimen have been received, participants will be scheduled for online or in-person semi-structured interviews. Semi-structured interviews will be conducted at baseline (either before or after surgery, but not both for the same individual) and at follow up.
Study Details
The MILES Study is a longitudinal, mixed-methods investigation of urinary biomarkers, energy balance, and lifestyle modifications in diverse women during early breast cancer treatment. The study's overarching goal is to assess dietary quality and physical activity changes over time using reliable, scalable tools suitable for clinical or population settings, supporting newly diagnosed patients in adopting and maintaining healthy behaviors through treatment and survivorship.
Key Dates
- Start date
- Jan 20, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Other: Newly diagnosed women with breast cancerAmong a sample of 100 women with newly diagnosed breast cancer, the study aims to collect novel lifestyle behavior data across three time points-at diagnosis, 1 month after surgery, and 6 months after surgery. Surveys will evaluate dietary quality, physical activity, tobacco use, demographic and socio-economic/occupation factors and perspectives about participation in biomedical/biospecimen research. The study will also collect the first urine of the day from these volunteers on the same day that they complete the lifestyle questionnaires. The urine will be used for metabolomics testing via Nuclear Magnetic Resonance (NMR) spectroscopy and will be correlated with the survey data.
Primary Outcome Measure
Change in lifestyle behavior score based [ Time Frame: Baseline, 1 month, 6 months ]
Central Contacts
- Julia Lewandowski215-913-2031
- Margaret Pichardo
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Abamson Cancer Center of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Margaret Pichardo, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and SerumRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Cardiotoxicity of Cancer Therapy (CCT)Enrolling By Invitation · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania
- PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast CancerRecruiting · Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania